Found: 20
Select item for more details and to access through your institution.
Immunomarker Studies of Fine-Needle Cytopuncture Cell Blocks for Tumor Response Prediction After Preoperative Chemotherapy and Prognosis in Operable Nonmetastatic Primary Breast Carcinoma.
- Published in:
- Breast Journal, 2011, v. 17, n. 2, p. 121, doi. 10.1111/j.1524-4741.2010.01040.x
- By:
- Publication type:
- Article
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Study of FHIT transcripts in normal and malignant breast tissue.
- Published in:
- Genes, Chromosomes & Cancer, 1998, v. 23, n. 4, p. 292, doi. 10.1002/(SICI)1098-2264(199812)23:4<292::AID-GCC3>3.0.CO;2-E
- By:
- Publication type:
- Article
Identification of molecular apocrine breast tumours by microarray analysis.
- Published in:
- Oncogene, 2005, v. 24, n. 29, p. 4660, doi. 10.1038/sj.onc.1208561
- By:
- Publication type:
- Article
A catalog of numerical centrosome defects in epithelial ovarian cancers.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 9, p. 1, doi. 10.15252/emmm.202215670
- By:
- Publication type:
- Article
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 2, p. 295, doi. 10.1007/s10549-017-4610-0
- By:
- Publication type:
- Article
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 2, p. 1, doi. 10.1093/jnci/djx159
- By:
- Publication type:
- Article
Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.813
- By:
- Publication type:
- Article
The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers.
- Published in:
- Journal of Pathology, 2018, v. 246, n. 1, p. 103, doi. 10.1002/path.5104
- By:
- Publication type:
- Article
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0670-9
- By:
- Publication type:
- Article
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cytologic Diagnosis of Lobular Carcinoma of the Breast.
- Published in:
- Cancer (0008543X), 2008, v. 114, n. 2, p. 111, doi. 10.1002/cncr.23347
- By:
- Publication type:
- Article
Erratum: A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.
- Published in:
- Nature Medicine, 2009, v. 15, n. 1, p. 68, doi. 10.1038/nm.1908
- By:
- Publication type:
- Article
Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 2, p. 659, doi. 10.1007/s10549-011-1839-x
- By:
- Publication type:
- Article
Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE 1 and BRD 4 genes in non-BRCAness high grade ovarian carcinoma.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 8, p. 1890, doi. 10.1002/ijc.29568
- By:
- Publication type:
- Article
Impact of tumor heterogeneity on disease-free survival in a series of 368 patients treated for a breast cancer.
- Published in:
- Diagnostic Pathology, 2013, v. 8, n. Suppl 1, p. 1, doi. 10.1186/1746-1596-8-S1-S43
- By:
- Publication type:
- Article
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
- Published in:
- British Journal of Cancer, 2019, v. 120, n. 9, p. 913, doi. 10.1038/s41416-019-0420-y
- By:
- Publication type:
- Article
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article